期刊文献+

膀胱移行细胞癌组织中环氧化酶-2的表达及其意义 被引量:6

The significance of the expression of cyclooxygenase-2 in bladder transitional cell carcinoma tissues
原文传递
导出
摘要 目的 探讨环氧化酶 2 (COX 2 )在膀胱移行细胞癌组织中的表达及其临床意义。方法应用逆转录 聚合酶链反应 (RT PCR)检测 5 2例膀胱移行细胞癌患者的癌组织及 17例患者距离肿瘤组织 3cm以外的正常膀胱黏膜组织中COX 2mRNA的表达 ,应用Westernblot法检测其中 4 9例膀胱癌组织及全部 17例正常膀胱黏膜组织中COX 2蛋白的表达 ,并应用条带密度分析软件半定量分析Westernblot条带密度。结果 COX 2mRNA在 83% (43/ 5 2 )的癌组织中表达 ,仅在 2 9% (5 / 17)的正常膀胱黏膜组织中表达 (P <0 .0 0 1) ;4 9例膀胱癌组织COX 2蛋白的表达量与肿瘤的分级、分期相关 (P<0 .0 0 1)。结论 COX 2在膀胱移行细胞癌组织中高表达 ,可能在肿瘤的发生发展中起一定的作用 ,可能成为膀胱癌化学预防的一个靶点。 Objective To investigate the expression of cyclooxygenase 2 (COX 2) in bladder transitional cell carcinoma tissues, and understand its clinical significance. Methods Reversal transcription polymerase chain reaction (RT PCR) was used to assess the expression of COX 2 mRNA in 52 cases of bladder transitional cell carcinoma tissues and 17 cases of normal bladder tissues far from neoplasm; Western blot was used to assess the expression of COX 2 protein in 49 cases of bladder cancerous tissues and 17 cases of normal tissues. Results Positive expression of COX 2 mRNA was detected in 83%(43/52) of bladder cancer tissues and in 29%(5/17) of normal tissues by RT PCR and there was significant difference in expression of COX 2 mRNA between cancer tissues and normal tissues. Western blot analysis showed that expression of COX 2 protein was correlation with the stage and grade of cancer. Conclusions COX 2 is overexpressed in bladder transitional cell carcinoma. COX 2 maybe play a certain role in carcinogenesis and progression of bladder cancer and turn into a useful target of chemoprevention of bladder cancer.
出处 《中华外科杂志》 CAS CSCD 北大核心 2004年第18期1104-1107,共4页 Chinese Journal of Surgery
关键词 癌组织中 膀胱移行细胞癌 表达量 COX-2 膀胱黏膜 正常 肿瘤 RNA 高表达 逆转录 Bladder carcinoma Cyclooxygenase 2 Gene expression
  • 相关文献

参考文献13

  • 1Subbaramaiah K, Zakim D, Weksler BB, et al. Inhibition of cyclooxygenase: a novel approach to cancer prevention. Pr℃ SoC Exp Bio Med, 1997, 216:201-210.
  • 2Thun MJ, Henley SJ, Patrono C. Nonsteroidal Anti-inflammatory Drugs as anticancer agents: mechanistic, pharmacyologic, and clinical issues. J Natl Cancer Inst, 2002, 94:252-266.
  • 3Mohammed SI, Knapp DW, Bostwick DG, et al. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res, 1999, 59:5647-5650.
  • 4Komhoff M, Guan Y, Shappell HW, et al. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. Am J Pathol, 2000, 157:29-35.
  • 5Shirahama T. Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder. Clin Cancer Res, 2000, 6:2424-2430.
  • 6Ristimaki A, Nieminen O, Saukkonen K, et al. Expression of Cyclooxygenase-2 in Human Transitional Cell Carcinoma of the Urinary Bladder. Am J Pathol, 2001, 158:849-853.
  • 7Badawi AF. The role of prostaglandin synthesis in prostate cancer. BJU Int, 2000, 85:451-462.
  • 8Marnett LJ. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res, 1992, 52:5575-5589.
  • 9Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 1995, 83:493-501.
  • 10Sheng H, Shoa J, Morrow JD, et al. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res, 1998, 58:362-366.

二级参考文献11

  • 1Komhoff M, Guan Y, Shappell HW, et al. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas [J]. Am J Pathol,2000,157: 29- 35.
  • 2Roberts PJ, Morgan K, Miller R, et al. Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease [J]. Gut,2001,48: 468- 472.
  • 3Eberhart CE, Coffey RJ, Radhika A,et al.Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas [J]. Gastroenterology,1994,107: 1183- 1188.
  • 4Half E, Tang XM, Gwyn K, et al. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ [J]. Cancer Res, 2002, 62: 1676- 1681.
  • 5Yoshimura R, Sano H, Masuda C,et al. Expression of cyclooxygenase-2 in prostate carcinoma [J].Cancer,2000, 89: 589- 596.
  • 6Hla T, Neilson K.Protein Human cyclooxygenase-2 cDNA [J]. Proc Natl Acad Sci USA, 1992,89: 7384- 7388.
  • 7Ristimaki A, Nieminen O, Saukkonen K,et al. Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder [J]. Am J Pathol, 2001, 158: 849- 853.
  • 8Tsujii M, DuBois RN. Alterations in celluar adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 [J]. Cell, 1995, 83: 493- 501.
  • 9Xie W, Herschman HR.v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor [J]. J Biol Chem,1995, 270: 27622- 27628.
  • 10Sheng H,Williams CS,Shao J,et al. Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway [J]. J Biol Chem,1998, 273: 22120- 22127.

共引文献7

同被引文献38

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部